Heroin-induced acute myelopathy with extreme high levels of CSF glial fibrillar acidic protein indicating a toxic effect on astrocytes

BMJ Case Rep. 2017 Jun 28:2017:bcr2017219903. doi: 10.1136/bcr-2017-219903.

Abstract

A man aged 33 years with previous heroin substance abuse was found unconscious lying in a bush. The patient had been without heroin for some time but had just started to use intravenous heroin again, 0.5-2 g daily. The patient had almost complete paraplegia and a sensory loss for all modalities below the mamillary level and a urine retention of 1.5 L. Acute MRI of the spine revealed an expanded spinal cord with increased intramedullary signal intensity, extending from C7-T9. The cerebrospinal fluid showed extremely high levels of nerve injury markers particularly glial fibrillar acidic protein (GFAP): 2 610 000/ng/L (ref. <750). The patient was empirically treated with intravenous 1 g methylprednisolone daily for 5 days and improved markedly. Very few diseases are known to produce such high levels of GFAP, indicating a toxic effect on astrocytes. Measuring GFAP could possibly aid in the diagnosis of heroin-induced myelopathy.

Keywords: Drug misuse (including addiction); Immunology; Neuroimaging; Neurology (drugs and medicines); Spinal cord.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Astrocytes / drug effects*
  • Biomarkers / cerebrospinal fluid
  • Drug Users
  • Glial Fibrillary Acidic Protein / cerebrospinal fluid*
  • Heroin / toxicity*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Methylprednisolone / therapeutic use
  • Paraplegia / cerebrospinal fluid
  • Paraplegia / chemically induced
  • Paraplegia / drug therapy
  • Sensation Disorders / cerebrospinal fluid
  • Sensation Disorders / chemically induced
  • Sensation Disorders / drug therapy
  • Spinal Cord / cytology
  • Spinal Cord / drug effects*
  • Spinal Cord Diseases / cerebrospinal fluid
  • Spinal Cord Diseases / chemically induced*
  • Spinal Cord Diseases / drug therapy
  • Substance Abuse, Intravenous

Substances

  • Biomarkers
  • Glial Fibrillary Acidic Protein
  • Heroin
  • Methylprednisolone